Monoamine Levels and Parkinson’s Disease Progression: Evidence From a High-Performance Liquid Chromatography Study

Parkinson’s disease (PD) is associated with dysfunction of monoamine neurotransmitter systems. We investigated changes in the levels of monoamine and their metabolites in PD patients, together with their association to clinical profiles. PD patients and age-matched control subjects (n = 40 per group...

Descripción completa

Detalles Bibliográficos
Autores principales: Wichit, Patsorn, Thanprasertsuk, Sekh, Phokaewvarangkul, Onanong, Bhidayasiri, Roongroj, Bongsebandhu-phubhakdi, Saknan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358115/
https://www.ncbi.nlm.nih.gov/pubmed/34393700
http://dx.doi.org/10.3389/fnins.2021.605887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358115/
https://www.ncbi.nlm.nih.gov/pubmed/34393700
http://dx.doi.org/10.3389/fnins.2021.605887

Ejemplares similares